📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Recombinant Lucilia sericata chymotrypsin in a topical hydrogel formulation degrades human wound eschar ex vivo. (2011)

First Author: Britland S

Attributed to: DPFS Devolved Portfolio (Pilot) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/btpr.587

PubMed Identifier: 21509949

Publication URI: http://europepmc.org/abstract/MED/21509949

Type: Journal Article/Review

Volume: 27

Parent Publication: Biotechnology progress

Issue: 3

ISSN: 1520-6033